Sandy Spring Bank’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $14.5M | Sell |
29,208
-396
| -1% | -$214K | 0.61% | 35 |
|
|
2024
Q4 | $15.4M | Buy |
29,604
+12
| +0% | +$6.6K | 0.62% | 33 |
|
|
2024
Q3 | $18.3M | Sell |
29,592
-345
| -1% | -$204K | 0.75% | 28 |
|
|
2024
Q2 | $16.6M | Buy |
29,937
+415
| +1% | +$238K | 0.73% | 26 |
|
|
2024
Q1 | $17.2M | Buy |
29,522
+157
| +0.5% | +$88.1K | 0.78% | 27 |
|
|
2023
Q4 | $15.6M | Buy |
29,365
+930
| +3% | +$450K | 0.78% | 26 |
|
|
2023
Q3 | $14.4M | Buy |
28,435
+127
| +0.4% | +$67.7K | 0.8% | 26 |
|
|
2023
Q2 | $14.8M | Buy |
28,308
+981
| +4% | +$529K | 0.79% | 27 |
|
|
2023
Q1 | $15.8M | Buy |
27,327
+232
| +0.9% | +$131K | 0.89% | 22 |
|
|
2022
Q4 | $14.9M | Sell |
27,095
-713
| -3% | -$378K | 0.89% | 23 |
|
|
2022
Q3 | $14.1M | Sell |
27,808
-1,199
| -4% | -$671K | 0.89% | 24 |
|
|
2022
Q2 | $15.8M | Sell |
29,007
-578
| -2% | -$318K | 0.95% | 21 |
|
|
2022
Q1 | $17.5M | Buy |
29,585
+749
| +3% | +$430K | 0.89% | 24 |
|
|
2021
Q4 | $19.2M | Buy |
28,836
+238
| +0.8% | +$149K | 0.92% | 25 |
|
|
2021
Q3 | $16.3M | Sell |
28,598
-207
| -0.7% | -$114K | 0.87% | 26 |
|
|
2021
Q2 | $14.5M | Buy |
28,805
+1,474
| +5% | +$695K | 0.77% | 30 |
|
|
2021
Q1 | $12.5M | Buy |
27,331
+966
| +4% | +$461K | 0.72% | 28 |
|
|
2020
Q4 | $12.3M | Buy |
26,365
+646
| +3% | +$303K | 0.75% | 28 |
|
|
2020
Q3 | $11.4M | Buy |
25,719
+931
| +4% | +$385K | 0.78% | 25 |
|
|
2020
Q2 | $8.98M | Buy |
24,788
+856
| +4% | +$287K | 0.67% | 35 |
|
|
2020
Q1 | $6.79M | Buy |
23,932
+1,199
| +5% | +$378K | 0.61% | 39 |
|
|
2019
Q4 | $7.38M | Sell |
22,733
-18
| -0.1% | -$5.46K | 0.54% | 48 |
|
|
2019
Q3 | $6.63M | Buy |
22,751
+986
| +5% | +$282K | 0.52% | 52 |
|
|
2019
Q2 | $6.39M | Buy |
21,765
+1,625
| +8% | +$448K | 0.51% | 49 |
|
|
2019
Q1 | $5.51M | Buy |
20,140
+1,655
| +9% | +$412K | 0.47% | 58 |
|
|
2018
Q4 | $4.14M | Buy |
18,485
+1,594
| +9% | +$374K | 0.4% | 69 |
|
|
2018
Q3 | $4.12M | Buy |
16,891
+1,707
| +11% | +$393K | 0.34% | 80 |
|
|
2018
Q2 | $3.15M | Buy |
15,184
+2,457
| +19% | +$522K | 0.27% | 97 |
|
|
2018
Q1 | $2.63M | Buy |
12,727
+1,147
| +10% | +$241K | 0.23% | 117 |
|
|
2017
Q4 | $2.2M | Buy |
11,580
+98
| +0.9% | +$18.8K | 0.2% | 137 |
|
|
2017
Q3 | $2.17M | Sell |
11,482
-181
| -2% | -$32.8K | 0.21% | 130 |
|
|
2017
Q2 | $2.03M | Sell |
11,663
-298
| -2% | -$50.1K | 0.2% | 136 |
|
|
2017
Q1 | $1.84M | Sell |
11,961
-135
| -1% | -$20.6K | 0.18% | 144 |
|
|
2016
Q4 | $1.71M | Buy |
12,096
+785
| +7% | +$116K | 0.18% | 152 |
|
|
2016
Q3 | $1.8M | Sell |
11,311
-150
| -1% | -$23.1K | 0.19% | 142 |
|
|
2016
Q2 | $1.69M | Buy |
11,461
+490
| +4% | +$72.3K | 0.19% | 139 |
|
|
2016
Q1 | $1.55M | Buy |
10,971
+2,123
| +24% | +$285K | 0.18% | 144 |
|
|
2015
Q4 | $1.25M | Buy |
8,848
+1,181
| +15% | +$158K | 0.15% | 159 |
|
|
2015
Q3 | $937K | Buy |
7,667
+1,684
| +28% | +$219K | 0.11% | 177 |
|
|
2015
Q2 | $776K | Buy |
5,983
+2,508
| +72% | +$327K | 0.09% | 185 |
|
|
2015
Q1 | $467K | Buy |
3,475
+1,100
| +46% | +$142K | 0.05% | 221 |
|
|
2014
Q4 | $298K | Buy |
+2,375
| New | +$289K | 0.04% | 232 |
|
Other funds holding TMO
Sandy Spring Bank's TMO Position: Q1 2025 in Review
Sandy Spring Bank reduced its Thermo Fisher Scientific (TMO) stake by 1.3% in Q1 2025, selling an estimated $214K and leaving 29,208 shares worth $14.5M. The position accounts for 0.61% of the portfolio, ranked #35.
Sandy Spring Bank first reported a position in TMO in Q4 2014 and has held it in 42 quarters since. The position peaked at $19.2M in Q4 2021. 2,571 funds tracked by Wall St. Rank hold TMO as of Q1 2025.
- Sandy Spring Bank held 29,208 shares of Thermo Fisher Scientific worth $14.5M as of Q1 2025.
- Sandy Spring Bank sold 396 Thermo Fisher Scientific shares in Q1 2025, an estimated $214K.
- Thermo Fisher Scientific made up 0.61% of Sandy Spring Bank's portfolio in Q1 2025, its #35 holding.
- Sandy Spring Bank first reported a position in Thermo Fisher Scientific in Q4 2014 and has held it in 42 quarters since.
- Sandy Spring Bank's Thermo Fisher Scientific position peaked at $19.2M in Q4 2021.
- 2,571 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2025.
Based on Sandy Spring Bank's 13F filing for Q1 2025, filed 12 May 2025.